Why the study?
Does intravenous acebutolol alter haemodynamic parameters in patients with stable congestive cardiomyopathy?
Does intravenous acebutolol alter haemodynamic parameters in patients with stable congestive cardiomyopathy?
Acute intravenous acebutolol in congestive cardiomyopathy significantly reduces left ventricular contractility and increases ventricular volumes, suggesting potential for hemodynamic deterioration despite some advantageous effects.
No takes yet. Share an insight, caveat, or question.
May signal risk of acute deterioration with IV acebutolol in cardiomyopathy; leaves open need for controlled trials.
Ikram et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: